-transparent.png){kind=logo}
Of 483 patients with biopsy-verified cirrhosis who entered the controlled trial of prednisone treatment conducted by the Copenhagen Study Group for Liver Diseases, 99 had alcoholic hepatitis as defined by morphological criteria in the initial biopsy. The maximum period of observation varied from 5 to 12 years. The survival of prednisone-treated patients (median survival time 38 months) and placebo-treated patients (median survival time 34 months) with alcoholic hepatitis did not differ significantly. This was also true for each of the two subgroups comprising mild and severe cases respectively. The presence of morphologically defined alcoholic hepatitis was postively correlated with the daily consumption of alcohol but poorly correlated with the clinical syndrome usually attributed to alcoholic hepatitis.
P Schlichting, and
E Juhl, and
H Poulsen, and
P Winkel
October 1985,
Liver,
P Schlichting, and
E Juhl, and
H Poulsen, and
P Winkel
September 1982,
Scandinavian journal of gastroenterology,
P Schlichting, and
E Juhl, and
H Poulsen, and
P Winkel
April 1961,
Acta medica Scandinavica,
P Schlichting, and
E Juhl, and
H Poulsen, and
P Winkel
September 2007,
Hepatology (Baltimore, Md.),
P Schlichting, and
E Juhl, and
H Poulsen, and
P Winkel
April 1975,
Medizinische Klinik,
P Schlichting, and
E Juhl, and
H Poulsen, and
P Winkel
July 1987,
The American journal of gastroenterology,
P Schlichting, and
E Juhl, and
H Poulsen, and
P Winkel
June 1973,
Deutsche medizinische Wochenschrift (1946),
P Schlichting, and
E Juhl, and
H Poulsen, and
P Winkel
January 1964,
Revue internationale d'hepatologie,
P Schlichting, and
E Juhl, and
H Poulsen, and
P Winkel
January 2009,
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
P Schlichting, and
E Juhl, and
H Poulsen, and
P Winkel
September 1989,
Revista espanola de las enfermedades del aparato digestivo,
